MyJournals Home  

RSS Feeds[ASAP] Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton`s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases (Journal of Medicinal Chemistry)

 
 

16 august 2019 00:02:08

 
[ASAP] Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton`s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases (Journal of Medicinal Chemistry)
 




Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.9b00794


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
37 viewsCategory: Chemistry, Medicine
 
[ASAP] Probing the Existence of a Metastable Binding Site at the 2-Adrenergic Receptor with Homobivalent Bitopic Ligands (Journal of Medicinal Chemistry)
[ASAP] Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? (Journal of Medicinal Chemistry)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn